Skip to main content
. 2020 May 14;9(1):1760685. doi: 10.1080/2162402X.2020.1760685

Figure 3.

Figure 3.

AXT201 alters tumor vasculature. (a) Immunohistochemical staining of water- and AXT201-treated tumors for CD31. (b) Quantification of CD31 staining area in water- and AXT201-treated tumors compared to the total area of the tumor slice. N = 3, *p < .05 Student’s t-test. (c) Immunofluorescence staining of water- and AXT201-treated tumors for CD31 (green) and NG2 (red). (d) Percentage of NG2 staining area overlapping with the CD31 staining area in water- and AXT201-treated tumors. N ≥ 3, *p < .05 Student’s t-test.